HIV/AIDS in the United States: Epidemiology and an Overview of High-Impact Prevention Measures
By Melody Lehosit, Kaplan University School of Health Sciences
A presentation for National Public Health Week.
Cardiovascular Disease: Hispanic Perspective
Max Solano M.D., St. Vincent’s Family Medicine Center – Coordinator of Healthy LifeStyle Initiatives Project
June 24, 2005 - UNF Hispanic Health Issues Seminar
This is part 5 of an 8 part series of seminars on Hispanic Health Issues brought to you by the University of North Florida’s Dept. of Public Health, College of Health, a grant from AETNA, and the cooperation of Duval County Health Department.
KAJIAN TAHAP PENGETAHUAN PENYAKIT HIV AIDS DALAM KALANGAN PELAJAR TINGKATAN 5...Muhammad Nasrullah
Ini merupakan Kajian bersama sekumpulan pelatih (Nas,Shu,Jamee dan Kucai)
PENGENALAN :. Penyakit AIDS (sindrom kurang daya tahan melawan penyakit) berpunca daripada virus HIV (Human Immunodeficiency virus ). secara ringkasnya merupakan penurunan daya keimunan terhadap serangan penyakit sehingga membawa maut.
KENYATAAN MASALAH Belakangan ini penularan penyakit HIV / AIDS menunjukkan trend peningkatan. Oleh itu melalui kajian penyelidik dapat menilai sejauh manakah pemahaman pelajar daripada kalangan remaja ini mengenai penyakit HIV / AIDS. Selain itu, Pengkaji juga cuba mengenalpasti faktor-faktor yang mempengaruhi tahap pengetahuan dan memberikan cadangan untuk mempertingkatkan pengetahuan pelajar tentang penyakit HIV / AIDS
METODOLOGI : Seramai 30 orang responden dipilih dalam kalangan pelajar tingkatan 5 SMK Tambun daripada pelbagai bangsa, agama dan jantina dipilih secara rawak. Kaedah kajian yang digunakan oleh penyelidik adalah deskriptif kuantitatif.
DAPATAN KAJIAN : Keputusan kajian mendapati faktor media massa dan elektronik yang paling banyak menyumbang dalam tahap pengetahuan pelajar mengenai penyakit HIV / AIDS iaitu sebanyak 90%. Namun, Faktor pengaruh rakan sebaya dan ibubapa paling kurang menyumbang iaitu hanya 10% dalam tahap pengetahuan pelajar .
CADANGAN ; Kempen-kempen tentang bahayanya penyakit AIDS haruslah dilakukan dengan lebih kerap tanpa mengira batasan umur dan sempadan geografi
Cardiovascular Disease: Hispanic Perspective
Max Solano M.D., St. Vincent’s Family Medicine Center – Coordinator of Healthy LifeStyle Initiatives Project
June 24, 2005 - UNF Hispanic Health Issues Seminar
This is part 5 of an 8 part series of seminars on Hispanic Health Issues brought to you by the University of North Florida’s Dept. of Public Health, College of Health, a grant from AETNA, and the cooperation of Duval County Health Department.
KAJIAN TAHAP PENGETAHUAN PENYAKIT HIV AIDS DALAM KALANGAN PELAJAR TINGKATAN 5...Muhammad Nasrullah
Ini merupakan Kajian bersama sekumpulan pelatih (Nas,Shu,Jamee dan Kucai)
PENGENALAN :. Penyakit AIDS (sindrom kurang daya tahan melawan penyakit) berpunca daripada virus HIV (Human Immunodeficiency virus ). secara ringkasnya merupakan penurunan daya keimunan terhadap serangan penyakit sehingga membawa maut.
KENYATAAN MASALAH Belakangan ini penularan penyakit HIV / AIDS menunjukkan trend peningkatan. Oleh itu melalui kajian penyelidik dapat menilai sejauh manakah pemahaman pelajar daripada kalangan remaja ini mengenai penyakit HIV / AIDS. Selain itu, Pengkaji juga cuba mengenalpasti faktor-faktor yang mempengaruhi tahap pengetahuan dan memberikan cadangan untuk mempertingkatkan pengetahuan pelajar tentang penyakit HIV / AIDS
METODOLOGI : Seramai 30 orang responden dipilih dalam kalangan pelajar tingkatan 5 SMK Tambun daripada pelbagai bangsa, agama dan jantina dipilih secara rawak. Kaedah kajian yang digunakan oleh penyelidik adalah deskriptif kuantitatif.
DAPATAN KAJIAN : Keputusan kajian mendapati faktor media massa dan elektronik yang paling banyak menyumbang dalam tahap pengetahuan pelajar mengenai penyakit HIV / AIDS iaitu sebanyak 90%. Namun, Faktor pengaruh rakan sebaya dan ibubapa paling kurang menyumbang iaitu hanya 10% dalam tahap pengetahuan pelajar .
CADANGAN ; Kempen-kempen tentang bahayanya penyakit AIDS haruslah dilakukan dengan lebih kerap tanpa mengira batasan umur dan sempadan geografi
Core practices that are moving from a pilot state to implementation at scale: Many of the
barriers facing HIV programs are common across countries. PEPFAR’s ECTs (described below in
Sections 2.3.2 and 2.3.3) identified common issues affecting countries at various levels of
epidemic control and then developed a compendium of evidence-based solutions, approaches
and case-studies that highlight successful means of addressing common barriers. Additional
evidence-based approaches and case-studies will be incorporated into this living compendium
over time. As highlighted in this PEPFAR Solutions Platform, these practices can be rapidly
adapted and scaled to move countries forward.
Key considerations for all PEPFAR programs include:
• Bringing Interventions to Scale with Fidelity: Getting to HIV epidemic control is dependent on
several factors; not the least of which is the ability to rapidly scale successful interventions with
fidelity and demonstrated impact. However, the logistics of cost- effective programmatic scale
have proven challenging, with several implementation barriers. Implementation science
defines scalability as the capacity to expand or extend an intervention to account for a growth
factor that aims to fill a gap or address unmet need in a defined population group/geographic
area.
• Data and Information Technology: The enabling environment for data and information
technology is rapidly maturing across countries, creating space, opportunity, and needed
political will to harness the Data Revolution for epidemic control. OUs should consider
innovative ways to use data and information technology to improve efficiency and
sustainability in achieving epidemic control, beyond immediate PEPFAR indicator data
collection needs. As highlighted in the Data Revolution Innovation Toolkit, available on the
PEPFAR SharePoint, OUs are encouraged to explore, adapt, and scale these and other data
driven approaches to move country epidemic control forward.
2022 Undergraduate Research Symposium: Malaak Elhage and Caroline Cohen
Analyzing the various neighborhoods in Detroit and the differing characteristics that make each one unique. Through the combination of our different topics, we hope to advance the research and recognition of Detroit's current outlook as well as the city's efforts to recover from its economic downturn due to Arab Americans being incorrectly categorized as "Caucasian" in many databases including the census, Arab Americans are overlooked and ignored in health research throughout the United States.
Over the years, we have seen various organizations including ACCESS and TAKE ON HATE, spearhead initiatives to change this narrative, challenge the persistent misconception of Arab Americans, as well as advocate for systematic policy changes (The Campaign to TAKE ON HATE). Before we can analyze the absence of Arab Americans in health data, it is crucial to understand what "Arab American" refers to. ACC Library Services define Arab Americans as "those who immigrated from or are descendants of immigrants who came from the predominantly Arabic-speaking nations in Southwest Asia and North Africa."
With the absence of an Arab American selection choice in health databases, individuals from 22 countries with rich, unique health factors and health history are pooled in with people with different health histories from different countries. This research will delve into the absence of Arab American data in Detroit, how race and inequality are not obvious, as depicted by Palmer Woods and Midtown data, and the problems that arise when Arab Americans are labeled by a religion and are categorized as Caucasian.
A panel study spanning 15 years which examines the characteristics of kids who run away from home and the long term impacts of run away behavior on key outcomes in adulthood.
Illustrating HIV/AIDS in the United States: Hispanic/Latino PersonsAIDSVu
AIDSVu offers a variety of tools to help illustrate the impact of HIV in the United States.Visit www.AIDSVu.org for more map views and downloadable resources.
Measuring Ethnic and Sexual Identities: Lessons from Two Studies in Central A...MEASURE Evaluation
Presentation led by Dr. Katherine Andrinopoulos, an Assistant Professor at Tulane University, John Hembling, M&E Specialist, and Tory M. Taylor, also an M&E Specialist.
Core practices that are moving from a pilot state to implementation at scale: Many of the
barriers facing HIV programs are common across countries. PEPFAR’s ECTs (described below in
Sections 2.3.2 and 2.3.3) identified common issues affecting countries at various levels of
epidemic control and then developed a compendium of evidence-based solutions, approaches
and case-studies that highlight successful means of addressing common barriers. Additional
evidence-based approaches and case-studies will be incorporated into this living compendium
over time. As highlighted in this PEPFAR Solutions Platform, these practices can be rapidly
adapted and scaled to move countries forward.
Key considerations for all PEPFAR programs include:
• Bringing Interventions to Scale with Fidelity: Getting to HIV epidemic control is dependent on
several factors; not the least of which is the ability to rapidly scale successful interventions with
fidelity and demonstrated impact. However, the logistics of cost- effective programmatic scale
have proven challenging, with several implementation barriers. Implementation science
defines scalability as the capacity to expand or extend an intervention to account for a growth
factor that aims to fill a gap or address unmet need in a defined population group/geographic
area.
• Data and Information Technology: The enabling environment for data and information
technology is rapidly maturing across countries, creating space, opportunity, and needed
political will to harness the Data Revolution for epidemic control. OUs should consider
innovative ways to use data and information technology to improve efficiency and
sustainability in achieving epidemic control, beyond immediate PEPFAR indicator data
collection needs. As highlighted in the Data Revolution Innovation Toolkit, available on the
PEPFAR SharePoint, OUs are encouraged to explore, adapt, and scale these and other data
driven approaches to move country epidemic control forward.
2022 Undergraduate Research Symposium: Malaak Elhage and Caroline Cohen
Analyzing the various neighborhoods in Detroit and the differing characteristics that make each one unique. Through the combination of our different topics, we hope to advance the research and recognition of Detroit's current outlook as well as the city's efforts to recover from its economic downturn due to Arab Americans being incorrectly categorized as "Caucasian" in many databases including the census, Arab Americans are overlooked and ignored in health research throughout the United States.
Over the years, we have seen various organizations including ACCESS and TAKE ON HATE, spearhead initiatives to change this narrative, challenge the persistent misconception of Arab Americans, as well as advocate for systematic policy changes (The Campaign to TAKE ON HATE). Before we can analyze the absence of Arab Americans in health data, it is crucial to understand what "Arab American" refers to. ACC Library Services define Arab Americans as "those who immigrated from or are descendants of immigrants who came from the predominantly Arabic-speaking nations in Southwest Asia and North Africa."
With the absence of an Arab American selection choice in health databases, individuals from 22 countries with rich, unique health factors and health history are pooled in with people with different health histories from different countries. This research will delve into the absence of Arab American data in Detroit, how race and inequality are not obvious, as depicted by Palmer Woods and Midtown data, and the problems that arise when Arab Americans are labeled by a religion and are categorized as Caucasian.
A panel study spanning 15 years which examines the characteristics of kids who run away from home and the long term impacts of run away behavior on key outcomes in adulthood.
Illustrating HIV/AIDS in the United States: Hispanic/Latino PersonsAIDSVu
AIDSVu offers a variety of tools to help illustrate the impact of HIV in the United States.Visit www.AIDSVu.org for more map views and downloadable resources.
Measuring Ethnic and Sexual Identities: Lessons from Two Studies in Central A...MEASURE Evaluation
Presentation led by Dr. Katherine Andrinopoulos, an Assistant Professor at Tulane University, John Hembling, M&E Specialist, and Tory M. Taylor, also an M&E Specialist.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
1. HIV/AIDS IN THE UNITED STATES:
EPIDEMIOLOGY AND AN
OVERVIEW OF HIGH-IMPACT
PREVENTION MEASURES
Melody Lehosit, CRNI MS
2. Introduction
• Epidemiology: Population
Trends of HIV Infection
• Male/Female
• Transmission
• Ethnicity/Race
• State Rates
• Living With HIV in the U.S.
• Deaths
• High-Impact Prevention
Measures
3. Diagnoses of HIV Infection Among Adults and Adolescents
by Sex, 2007–2010, 46 States and 5 U.S. Dependent Areas
Note: Data includes persons with a diagnosis of HIV infection regardless of the stage of the disease at diagnosis. All displayed
data has been statistically adjusted to account for reporting delays, but not for incomplete reporting.
4. Diagnoses of HIV Infection Among Adults and Adolescents
by Sex and Transmission Category, 2010, 46 States and 5
U.S. Dependent Areas
Note: Data includes persons with a diagnosis of HIV infection regardless of the stage of the disease at diagnosis. All displayed data
has been statistically adjusted to account for reporting delays and missing risk-factor information, but not for incomplete
reporting.
a Heterosexual contact with a person known to have, or to be at high-risk for, HIV infection.
b Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or not identified.
5. Trends in Sex and Transmission
2010 Transmission in
• 48,079 new DX Males
• Males: 74 percent • Male-to-male: 77 percent
• Females: 21percent
Transmission in
Females
• Heterosexual contact:
86 percent
*These rates have been stable
for the past 3 years. *Rates of new male-to-male
transmission infections increased
from 55 percent to 61percent.
(CDC, 2011)
6. Diagnoses of HIV Infection Among Adults and Adolescents, by
Race/Ethnicity, 2007–2010, 46 States and 5 U.S. Dependent Areas
Note: Data includes persons with a diagnosis of HIV infection regardless of the stage of the disease at diagnosis. All displayed data
has been statistically adjusted to account for reporting delays, but not for incomplete reporting.
a Hispanics/Latinos can be of any race.
7. Diagnoses of HIV Infection Among Adults and Adolescents by Sex
and Race/Ethnicity, 2010, 46 States 5 U.S. Dependent Areas
Note: Data includes persons with a diagnosis of HIV infection regardless of the stage of the disease at diagnosis. All displayed
data has been statistically adjusted to account for reporting delays, but not for incomplete reporting.
a Hispanics/Latinos can be of any race.
9. Diagnosed HIV Infections Attributed to Male-to-Male Sexual Contact,
by Race/Ethnicity, 2010, 46 States and 5 U.S. Dependent Areas
Race/Ethnicity No. %
American Indian/Alaska Native 119 0.4
Asian 584 2.0
Black/African American 10,842 37.1
a
Hispanic/Latino 6,803 23.3
Native Hawaiian/Other Pacific Islander 53 0.2
White 10,396 35.6
Multiple Races 396 1.4
Total 29,194 100.0
Note: Data includes persons with a diagnosis of HIV infection regardless of the stage of the disease at diagnosis. All displayed
data has been statistically adjusted to account for reporting delays and missing risk-factor information, but not for incomplete
reporting.
a Hispanics/Latinos can be of any race.
10. Diagnosed HIV Infections Attributed to Injection Drug Use, by Sex
and Race/Ethnicity, 2010, 46 States and 5 U.S. Dependent Areas
Males Females Total
Race/Ethnicity No. % No. % No.
American Indian/Alaska Native 6 0.2 15 1.1 21
Asian 22 0.9 9 0.6 31
Black/African American 1, 203 46.6 725 50.9 1,928
a
Hispanic/Latino 836 32.4 220 15.4 1,056
Native Hawaiian/Other Pacific Islander 2 0.1 1 0.1 4
White 487 18.9 432 30.3 918
Multiple Races 25 1.0 24 1.7 49
Total 2,581 100.0 1,426 100.0 4,007
Note: Data includes persons with a diagnosis of HIV infection regardless of the stage of the disease at diagnosis. All displayed
data has been statistically adjusted to account for reporting delays and missing risk-factor information, but not for
incomplete reporting.
a Hispanics/Latinos can be of any race.
11. 2010 Trends by Number (N)
High and Increased Transmission
• Male-to-Male: 29,194
• Heterosexual Contact: 13,357
By Race
• Black/African American: 10,842
• White: 10,396
• Hispanic/Latino: 6,803
By Race—IV Drug Use
• Black/African American: 1,928
• Hispanic/Latino: 1,056
• White: 918
(CDC, 2011)
12. Rates of Diagnoses of HIV Infection Among Adults and
Adolescents, 2010, 46 States and 5 U.S. Dependent Areas
N = 48,079
Note: Data includes persons with a diagnosis of HIV infection regardless of the stage of the disease at diagnosis. All displayed data has been
statistically adjusted to account for reporting delays, but not for incomplete reporting.
13. Rates of Adults and Adolescents Living With an AIDS Diagnosis,
2009, United States and 6 U.S. Dependent Areas
N = 487,414
Note: All displayed data has been statistically adjusted to account for reporting delays, but not for incomplete reporting.
14. What to Do?
• Overall rates stable
• Black/African American male rates increasing
• Latino rates disproportionate, increasing
• Male-to-male transmission rates increasing
• Urban rates increasing
• Female heterosexual rates of transmission
(CDC, 2012)
15. Prevention Works
• More people living with HIV
• People in the U.S. know their status
• Stable rates?
• CDC estimates 5 transmissions per 100 people
living with HIV
• Specific targets needed
(CDC, 2012)
16. High-Impact Prevention
National HIV/AIDS Strategy Target High-Risk Groups
• Science/Medication • Gay and Bisexual Men
• Cost Efficiency • Communities of Color
• Specific Interventions • Women
• Geography
• Youth
• IV Drug Users
• Transgendered
(CDC, 2011a)
17. Funding Decisions
Partners Cities
• National Association of State and • Atlanta
Territorial AIDS Directors (NASTAD)
• Urban Coalition for HIV/AIDS • Baltimore
Prevention Services (UCHAPS) • Chicago
• National Minority AIDS Council • Fort Lauderdale
(NMAC)
• National Association of County and • Houston
City Health Officials (NACCHO) • Los Angeles
• The AIDS Institute • New York
• Local, state, and territorial health
departments • Miami
Allocation • Philadelphia
• San Francisco
• Minimum funding to all jurisdictions
• Matched funds to burden
• 37 percent of Americans
• Competitive funding projects
with HIV live in these 10
• Direct funding for heavily affected
cities
cities
(CDC, 2011b)
18. 5-Year Plan
Goals Plan Priorities
• Lower new infections by 25 percent • Intensify HIV prevention in
communities where HIV is most
• Increase percentage of people living heavily concentrated
with HIV who know of their infection
from 79 percent to 90 percent
• Expand targeted use of effective
• Reduce HIV transmission rate by combinations of evidence-based HIV
30 percent prevention approaches
• Increase those linked to care within 3
months from 65 percent to 85 • Educate all Americans about the
percent threat of HIV and how to prevent it
• Increase the proportion of HIV-
• Increase the dialog—like we are
diagnosed gay and bisexual men,
African Americans, and Hispanic/ doing today
Latinos with undetectable viral load
by 20 percent (treatment works!)
(CDC, 2011a)
19. Proven HIV • HIV testing and linkage to care
Interventions • Comprehensive prevention with HIV positive
individuals
• Condom distribution
• Antiretroviral therapy
• Access to condoms and sterile syringes
• Prevention programs for people living with HIV
and their partners (social marketing, media,
and mobilization)
• Prevention programs for people at high risk of
HIV infection
• Substance abuse treatment
• Screening and treatment for other sexually
transmitted infections
(CDC, 2111b)
20. HIV Testing
• Routine Ages 13 to 64 in health care settings (opt-out)
• Routine All pregnant women
• Targeted Gay PRIDE events, fairs, parks, drug-treatment clinics;
increased targeting in specific communities
• Screening STD and HIV testing
(Bowles, et al. 2008; CDC, 2011b)
21. Comprehensive Prevention
• Make the call: Link to care and treatment
• Test for efficacy: Reduce viral loads with treatment
• Ask and educate: Improve compliance with medication
• Behavioral interventions for HIV-positive individuals
• Availability of condoms
• Availability of sterile needles
• Interventions to prevent mother-to-child HIV transmission
• ARV medication
• Partner testing/counseling during L/D
• Referrals
• Other medical services (social services, substance abuse)
• Mental health services (CDC, 2111b)
22. AVR
• Antiretroviral Therapy
• Treating early means less transmission
• Pre-Exposure Prophylaxis (PrEP)
• Planning, education, personnel, supported (no meds
with CDC funds)
• Non-Occupational Post-Exposure Prophylaxis (nPEP)
for High-Risk Groups
23. Intervention Summary
HIV testing
• Including routine opt-out testing in health care
settings and targeted testing programs for high-risk
populations
Prevention with HIV-positive individuals
• Helping people living with HIV reduce their risk of
transmitting HIV to others
Condom and needle distribution
• Available for people at high risk of acquiring HIV
Geographic focus
• Increasing funding to cities with higher incidences
Structural initiatives
• Aligning structures, policies, and regulations to
enable optimal HIV prevention, care, and treatment
(CDC, 2011a)
24. High-Impact Prevention (CDC)
• Health Department funding
• $359 million annually, FY 2012–FY 2016 (assumes level funding)
• Better matching for HIV prevention dollars
• Expanded testing initiative
• Saving lives and money
26. References
• Centers for Disease Control, [CDC]. (2011). HIV Surveillance - Epidemiology of HIV Infection
[PowerPoint]. Retrieved from www.cdc.gov/hiv/topics/surveillance/resources/slides/general/
• Centers for Disease Control, [CDC]. (2011a). High-impact HIV prevention. Retrieved from
www.cdc.gov/hiv/strategy/dhap/pdf/nhas_booklet.pdf
• Centers for Disease Control. [CDC]. (2011b). CDC’S new high-impact approach to HIV prevention
funding for health departments. Retrieved from www.cdc.gov/hiv/topics/funding/PS12-
1201/resources/factsheet/pdf/foa-partner.pdf
• Centers for Disease Control. (2012). e-HAP information from the CDC’s division of HIV/AIDS
prevention. Retrieved from www.cdc.gov/hiv/ehap/resources/fyi/031412/index.htm
• Boles, K., et.al. (2007). Implementing rapid HIV testing in outreach and community settings: Results
from an advancing HIV prevention demonstration project conducted in seven U.S. cities. Public
Health Reports s3(123) Retrieved from
www.publichealthreports.org/archives/issueopen.cfm?articleID=2137